Literature DB >> 29434976

Prediction of long-term survival rates in patients undergoing curative resection for solitary hepatocellular carcinoma.

Yi Cao1,2, Zhelong Jiang1, Shaohu Wang1,3, Haoyang Zhang4, Yi Jiang1,2,3, Lizhi Lv1,2.   

Abstract

The present study developed a novel laboratory-based algorithm to predict long-term survival rates in patients undergoing curative resection for solitary hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC). The present study included 426 patients with solitary HBV-related HCC who underwent surgery for primary tumors at a single center between 2003 and 2012. Demographic characteristics, laboratory analysis, clinical pathology and immunohistochemistry of topoisomerase II-a and Ki67 were analyzed. A simple prognostic risk calculator was developed using regression coefficients from multivariate models. A prognostic risk calculator incorporating tumor encapsulation, neutrophil-to-lymphocyte ratio, vascular invasion, α-fetoprotein level, Edmondson-Steiner classification, Topo II-α, prognostic nutritional index and Child-Pugh grade was constructed. The prognostic model demonstrated good discrimination with a C-index prior to adjustment of 0.81 (95% confidence interval: 0.78-0.84) and a bootstrap-corrected C-index of 0.81. Kaplan-Meier curves demonstrated that the probabilities of overall survival rates in the low-risk group were increased compared with those in the high-risk group. The areas under the receiver operating characteristic curve using the method were greater compared with those under the 7th Tumor-Node-Metastasis system and Cancer of the Liver Italian Program scoring system [0.83 vs. 0.62 and 0.77 (P<0.001), respectively]. The simple prognostic model of the present study accurately predicted survival rates in patients. Such a prognostic risk calculator for staging patients undergoing curative resection for solitary HBV-related HCC facilitates clinical surveillance and therapy.

Entities:  

Keywords:  curative resection; hepatocellular carcinoma; neutrophil-to-lymphocyte ratio; prognostic nutritional index; topoisomerase II-α

Year:  2017        PMID: 29434976      PMCID: PMC5777370          DOI: 10.3892/ol.2017.7612

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  32 in total

1.  Prospective validation of the Cancer of the Liver Italian Program (CLIP) score: a new prognostic system for patients with cirrhosis and hepatocellular carcinoma.

Authors:  J M Llovet; J Bruix
Journal:  Hepatology       Date:  2000-09       Impact factor: 17.425

Review 2.  Clinicopathological and prognostic significance of high Ki-67 labeling index in hepatocellular carcinoma patients: a meta-analysis.

Authors:  Yihuan Luo; Fanghui Ren; Yongru Liu; Zhenhong Shi; Zhong Tan; Huojie Xiong; Yiwu Dang; Gang Chen
Journal:  Int J Clin Exp Med       Date:  2015-07-15

Review 3.  C-Reactive Protein as a Prognostic Marker in Patients with Hepatocellular Carcinoma.

Authors:  Akiyoshi Kinoshita; Hiroshi Onoda; Nami Imai; Hirokazu Nishino; Hisao Tajiri
Journal:  Hepatogastroenterology       Date:  2015-06

4.  Hepatectomy for huge hepatocellular carcinoma: single institute's experience.

Authors:  Lianyue Yang; Jiangfeng Xu; Dipeng Ou; Wei Wu; Zhijun Zeng
Journal:  World J Surg       Date:  2013-09       Impact factor: 3.352

5.  Platelet-to-lymphocyte ratio acts as a prognostic factor for patients with advanced hepatocellular carcinoma.

Authors:  Xing Li; Zhan-Hong Chen; Yan-Fang Xing; Tian-Tian Wang; Dong-Hao Wu; Jing-Yun Wen; Jie Chen; Qu Lin; Min Dong; Li Wei; Dan-Yun Ruan; Ze-Xiao Lin; Xiang-Yuan Wu; Xiao-Kun Ma
Journal:  Tumour Biol       Date:  2014-11-21

6.  Nomograms for Pre- and Postoperative Prediction of Long-term Survival for Patients Who Underwent Hepatectomy for Multiple Hepatocellular Carcinomas.

Authors:  Pinghua Yang; Jiliang Qiu; Jun Li; Dong Wu; Xuying Wan; Wan Yee Lau; Yunfei Yuan; Feng Shen
Journal:  Ann Surg       Date:  2016-04       Impact factor: 12.969

7.  Tissue expression of squamous cellular carcinoma antigen and Ki67 in hepatocellular carcinoma-correlation with prognosis: a historical prospective study.

Authors:  Hemda Schmilovitz-Weiss; Ana Tobar; Marisa Halpern; Izhar Levy; Esther Shabtai; Ziv Ben-Ari
Journal:  Diagn Pathol       Date:  2011-12-07       Impact factor: 2.644

8.  Edmondson-Steiner grade: A crucial predictor of recurrence and survival in hepatocellular carcinoma without microvascular invasio.

Authors:  Li Zhou; Jing-An Rui; Wei-Xun Zhou; Shao-Bin Wang; Shu-Guang Chen; Qiang Qu
Journal:  Pathol Res Pract       Date:  2017-03-08       Impact factor: 3.250

Review 9.  Hallmarks of cancer: the next generation.

Authors:  Douglas Hanahan; Robert A Weinberg
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582

10.  Body mass index and cholesterol level predict surgical outcome in patients with hepatocellular carcinoma in Taiwan - a cohort study.

Authors:  Ya-Ling Lee; Wan-Chun Li; Tung-Hu Tsai; Hsin-Yu Chiang; Chin-Tsung Ting
Journal:  Oncotarget       Date:  2016-04-19
View more
  5 in total

1.  Prognostic Nomograms for Patients with Hepatocellular Carcinoma After Curative Hepatectomy, with a Focus on Recurrence Timing and Post-Recurrence Management.

Authors:  Wei Xu; Fei Liu; Xianbo Shen; Ruineng Li
Journal:  J Hepatocell Carcinoma       Date:  2020-10-27

2.  Texture analysis on gadoxetic acid enhanced-MRI for predicting Ki-67 status in hepatocellular carcinoma: A prospective study.

Authors:  Zheng Ye; Hanyu Jiang; Jie Chen; Xijiao Liu; Yi Wei; Chunchao Xia; Ting Duan; Likun Cao; Zhen Zhang; Bin Song
Journal:  Chin J Cancer Res       Date:  2019-10       Impact factor: 5.087

3.  Effect of KI-67 positive cellular index on prognosis after hepatectomy in Barcelona Clinic Liver Cancer stage A and B hepatocellular carcinoma with microvascular invasion.

Authors:  Hong-Hao Li; Lu-Nan Qi; Liang Ma; Zu-Shun Chen; Bang-De Xiang; Le-Qun Li
Journal:  Onco Targets Ther       Date:  2018-08-10       Impact factor: 4.147

4.  Underlying liver disease and advanced stage liver cancer are associated with elevated neutrophil-lymphocyte ratio.

Authors:  Linda Wong; Kliment Bozhilov; Brenda Hernandez; Sandi Kwee; Owen Chan; Luke Ellis; Loic LeMarchand
Journal:  Clin Mol Hepatol       Date:  2019-04-19

5.  Neutrophil to lymphocyte and platelet to lymphocyte ratios as biomarkers to predict relapse and survival in posthepatectomy HBV-related hepatocellular carcinoma: a meta-analysis and preliminary immune perspective.

Authors:  Xia Zheng; Bin Ye; Yudong Gou; Zixiong Li; Chao Chen; Feng Liao; Xiufeng Liu; Shukui Qin
Journal:  Transl Cancer Res       Date:  2021-03       Impact factor: 1.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.